Opexa Therapeutics, Inc. (OPXA) Reports Q3 Loss of $0.10

Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q3 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
• LENSAR, Inc. (LNSR) Tops Q2 EPS by 31c